About Codagenix
Codagenix is a company based in Stony Brook (United States) founded in 2011.. Codagenix has raised $47.1 million across 14 funding rounds from investors including Serum Institute of India, United States Department of Agriculture and NIH. Codagenix offers products and services including Live-Attenuated Vaccines, Virotherapeutic Platform, and Codon Deoptimization Technology. Codagenix operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Adaptive Biotechnologies, among others.
- Headquarter Stony Brook, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Codagenix Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$47.1 M (USD)
in 14 rounds
-
Latest Funding Round
$10 M (USD), Grant
Oct 13, 2023
-
Investors
Serum Institute of India
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Codagenix
Codagenix offers a comprehensive portfolio of products and services, including Live-Attenuated Vaccines, Virotherapeutic Platform, and Codon Deoptimization Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccines engineered for infectious diseases using synthetic biology.
Therapeutics designed for cancer treatment via viral genome edits.
Technology for creating stable viral edits in animal health applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Codagenix
Codagenix has successfully raised a total of $47.1M across 14 strategic funding rounds. The most recent funding activity was a Grant round of $10 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $10.0M
-
First Round
First Round
(15 Jun 2012)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Grant - Codagenix | Valuation |
investors |
|
| Feb, 2023 | Amount | Series B - Codagenix | Valuation | Serum Institute of India , Euclidean Capital | |
| Jul, 2020 | Amount | Grant - Codagenix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Codagenix
Codagenix has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Serum Institute of India, United States Department of Agriculture and NIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is deployed for global health technology innovations.
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by this single-family office.
|
Founded Year | Domain | Location | |
|
Biotech sectors are targeted for investments by Topspin Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Codagenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Codagenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Codagenix Comparisons
Competitors of Codagenix
Codagenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Adaptive Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Codagenix
Frequently Asked Questions about Codagenix
When was Codagenix founded?
Codagenix was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Codagenix located?
Codagenix is headquartered in Stony Brook, United States. It is registered at Stony Brook, New York, United States.
Is Codagenix a funded company?
Codagenix is a funded company, having raised a total of $47.1M across 14 funding rounds to date. The company's 1st funding round was a Grant of $4.75M, raised on Jun 15, 2012.
What does Codagenix do?
Codagenix was founded in 2011 and is located in Stony Brook, United States. Live-attenuated viral vaccines are developed by the company within the biotechnology sector, focusing on infectious diseases. The proprietary SAVE platform is utilized, which employs synthetic biology to redesign the entire genome of target viruses and produce vaccine strains. Operations center on a preclinical pipeline that addresses seasonal influenza, dengue virus, respiratory syncytial virus, and pandemic influenza.
Who are the top competitors of Codagenix?
Codagenix's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Codagenix offer?
Codagenix offers Live-Attenuated Vaccines, Virotherapeutic Platform, and Codon Deoptimization Technology.
Who are Codagenix's investors?
Codagenix has 8 investors. Key investors include Serum Institute of India, United States Department of Agriculture, NIH, HHS, and Adjuvant Capital.